Anonymous
Guest
Anonymous
Guest
Hard to believe it's been two plus years...
"We look forward to introducing our tissue sealing device, the Altrus Thermal Tissue Fusion System, to the surgical community," noted Joseph J. Corasanti, President and CEO of CONMED. "We believe the current marketplace for energy based instruments approximates $1.5 billion, and while our initial revenue goals for Altrus in 2011 are modest at $5 - $10 million, we expect Altrus® to be a contributor to our long-term growth prospects."
Even harder to believe how far from original sales estimates Altrus has fallen.
"We look forward to introducing our tissue sealing device, the Altrus Thermal Tissue Fusion System, to the surgical community," noted Joseph J. Corasanti, President and CEO of CONMED. "We believe the current marketplace for energy based instruments approximates $1.5 billion, and while our initial revenue goals for Altrus in 2011 are modest at $5 - $10 million, we expect Altrus® to be a contributor to our long-term growth prospects."
Even harder to believe how far from original sales estimates Altrus has fallen.